National Pharmaceutical Pricing Authority (NPPA) notification up to 87% of the price of 9 drug combinations used by cancer patients and transfusion surgeries.
National Pharmaceutical Pricing Authority (NPPA) notification up to 87% of the price of 9 drug combinations used by cancer patients and transfusion surgeries. NPPA, which has a profit of 30 per cent in pharmaceutical compounds, has also restricted the price of 42 cancer drugs previously. It is estimated that at least 85% of the price of 355 branded drugs, including 72 chemicals, will be cheaper.
The price control was based on the report submitted by pharmaceutical companies in relation to production costs. Errolinib 100 Mg of Tab 10 is priced at Rs 1840 (older than Rs 6600), Erlotinib 150 Mg Tab 10 is priced at Rs 2400 (Old Price 9600) Luprolide Azarate 3.75 Mg Injection Rs 2650 (Rs 3990).
National Pharmaceutical Pricing Authority (NPPA) notification up to 87% of the price of 9 drug combinations used by cancer patients and transfusion surgeries. NPPA, which has a profit of 30 per cent in pharmaceutical compounds, has also restricted the price of 42 cancer drugs previously. It is estimated that at least 85% of the price of 355 branded drugs, including 72 chemicals, will be cheaper.
The price control was based on the report submitted by pharmaceutical companies in relation to production costs. Errolinib 100 Mg of Tab 10 is priced at Rs 1840 (older than Rs 6600), Erlotinib 150 Mg Tab 10 is priced at Rs 2400 (Old Price 9600) Luprolide Azarate 3.75 Mg Injection Rs 2650 (Rs 3990).
Tags:
health info